These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38509655)

  • 21. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
    J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiological evidence on the carcinogenicity of beryllium in humans.
    MacMahon B
    J Occup Med; 1994 Jan; 36(1):15-24; discussion 25-6. PubMed ID: 8138844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mortality study of beryllium workers.
    Boffetta P; Fordyce TA; Mandel JS
    Cancer Med; 2016 Dec; 5(12):3596-3605. PubMed ID: 27766788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
    Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
    Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Beryllium Disease: Update on a Moving Target.
    MacMurdo MG; Mroz MM; Culver DA; Dweik RA; Maier LA
    Chest; 2020 Dec; 158(6):2458-2466. PubMed ID: 32768458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort.
    Schuler CR; Kitt MM; Henneberger PK; Deubner DC; Kreiss K
    J Occup Environ Med; 2008 Dec; 50(12):1343-50. PubMed ID: 19092488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic beryllium: new solutions for a chronic problem.
    Fields S
    Environ Health Perspect; 2001 Feb; 109(2):A74-9. PubMed ID: 11266347
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic beryllium disease: uncommon disease, less common diagnosis.
    Middleton DC
    Environ Health Perspect; 1998 Dec; 106(12):765-7. PubMed ID: 9831535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of beryllium sensitized workers from a single employer.
    Duggal M; Deubner DC; Curtis AM; Cullen MR
    BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis.
    Verma DK; Ritchie AC; Shaw ML
    Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beryllium.
    Deubner DC
    J Occup Environ Hyg; 2005 Oct; 2(10):D74-6; author reply D76-8. PubMed ID: 16174633
    [No Abstract]   [Full Text] [Related]  

  • 36. Beryllium copper alloy (2%) causes chronic beryllium disease.
    Balkissoon RC; Newman LS
    J Occup Environ Med; 1999 Apr; 41(4):304-8. PubMed ID: 10224597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
    Markham TN
    Int Arch Occup Environ Health; 1996; 68(6):405-7. PubMed ID: 8891776
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of beryllium sensitization and chronic beryllium disease.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518
    [No Abstract]   [Full Text] [Related]  

  • 39. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada.
    Ribeiro M; Fritscher LG; Al-Musaed AM; Balter MS; Hoffstein V; Mazer BD; Maier LA; Liss GM; Tarlo SM
    Lung; 2011 Jun; 189(3):233-41. PubMed ID: 21400234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
    Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
    Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.